Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany.

Sleep medicine

Volumn 14, Issue 6, 2013, Pages 475-481

  Stiasny Kolster, Karin ^a   Berg, Daniela ^b   Hofmann, Werner E ^b   Berkels, Reinhard ^b   Grieger, Frank ^b   Lauterbach, Thomas ^b   Schollmayer, Erwin ^b   Bachmann, Cornelius G ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; ROTIGOTINE; TETRALIN DERIVATIVE; THIOPHENE DERIVATIVE;

AGED; CLINICAL TRIAL; DRUG SELF ADMINISTRATION; FEMALE; GERMANY; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RESTLESS LEGS SYNDROME; TRANSDERMAL PATCH; TREATMENT OUTCOME;

AGED; BENZOTHIAZOLES; DOPAMINE AGONISTS; FEMALE; GERMANY; HUMANS; LEVODOPA; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; SELF ADMINISTRATION; TETRAHYDRONAPHTHALENES; THIOPHENES; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 84893345906     PISSN: None     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2013.02.013     Document Type: Article

References (19)

1. C. Trenkwalder W. Paulus Restless legs syndrome: pathophysiology, clinical presentation and management Nat Rev Neurol 6 2010 337 346
2. C.J. Earley M.H. Silber Restless legs syndrome: understanding its consequences and the need for better treatment Sleep Med 11 2010 807 815
3. D. Tzonova O. Larrosa E. Calvo J.J. Granizo A.M. Williams Y. de la Llave Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease) Sleep Med 13 2012 151 155
4. H. Scholz C. Trenkwalder R. Kohnen D. Riemann L. Kriston M. Hornyak Dopamine agonists for restless legs syndrome Cochrane Database Syst Rev 2011 CD006009
5. D. Garcia-Borreguero L. Ferini-Strambi R. Kohnen S. O’Keeffe C. Trenkwalder B. Högl European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society Eur J Neurol 2012 10.1111/j.468-331.2012.03853.x
6. C. Trenkwalder H. Beneš M. Hornyak D. Riemannn K. Stiasny-Kolster J. Winkelmann Restless-legs-syndrome (RLS) und periodic limb movement disorder (PLMD) Leitlinien für Diagnostik und Therapie in der Neurologie 2008 Georg Thieme Verlag Stuttgart
7. D. Scheller C. Ullmer R. Berkels M. Gwarek H. Lubbert The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease Naunyn Schmiedebergs Arch Pharmacol 379 2009 73 86
8. J.P. Elshoff M. Braun J.O. Andreas M. Middle W. Cawello Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies Clin Ther 34 2012 966 978
9. W.H. Oertel H. Beneš D. Garcia-Borreguero P. Geisler B. Högl B. Saletu Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe Sleep Med 9 2008 228 239
10. C. Trenkwalder H. Benes W. Poewe W.H. Oertel D. Garcia-Borreguero A.W. de Weerd Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial Lancet Neurol 7 2008 595 604
11. W.A. Hening R.P. Allen W.G. Ondo A.S. Walters J.W. Winkelman P. Becker Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States Mov Disord 25 2010 1675 1683
12. W.H. Oertel H. Benes D. Garcia-Borreguero B. Hogl W. Poewe P. Montagna Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study Sleep Med 11 2010 848 856
13. W. Oertel C. Trenkwalder H. Beneš L. Ferini-Strambi B. Högl W. Poewe Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study Lancet Neurol 10 2011 710 720
14. UCB Pharma Limited. Neupro. European summary of product characteristics, 2010. Available: http://www.medicines.org.uk/EMC/medicine/21963/SPC/Neupro . Accessed 17 October 2012.
15. R. Kohnen W. Oertel K. Stiasny-Kolster H. Beneš C. Trenkwalder Severity rating of restless legs syndrome: validation of the RLS-6 scales Sleep 27 2004 A304
16. D. Garcia-Borreguero P. Stillman H. Benes H. Buschmann K.R. Chaudhuri V.M. Gonzalez Rodriguez Algorithms for the diagnosis and treatment of restless legs syndrome in primary care BMC Neurol 11 2011 28
17. D. Garcia-Borreguero A.M. Williams Dopaminergic augmentation of restless legs syndrome Sleep Med Rev 14 2010 339 346
18. R.P. Allen W.G. Ondo E. Ball M.O. Calloway R. Manjunath R.L. Higbie Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample Sleep Med 12 2011 431 439
19. H. Beneš D. Garcia-Borreguero L. Ferini-Strambi E. Schollmayer A. Fichtner R. Kohnen Augmentation in the treatment of restless legs syndrome with transdermal rotigotine Sleep Med 13 2012 589 597